Araştırma Makalesi
BibTex RIS Kaynak Göster

Özel Virüs Aşıları - 1

Yıl 2012, Cilt: 12 Sayı: 1, 42 - 45, 01.01.2012

Öz

Özet

Bağışıklamada amaç; toplumda, özellikle bebek ve çocuklarda aşı ile korunabilir hastalıkların önüne geçmektir. Rutin aşı takvimimizde olmayan ancak toplumda sık gördüğümüz hastalıklara karşı virüs aşıları mevcuttur.

Kaynakça

  • 1. The Pink Book: Course Textbook - 12th Edition, chapter 8.
  • 2. Prevention of Hepatitis A through active or passive immunization: Recommendations of Advisory Committee on Immunization Practices (ACIP).MMWR 2006; 55 (No. RR-7): 1-23.
  • 3. Bell BP. Feinstone SM. Hepatitis A vaccine.In: Vaccines,Ed. By Plotkin SA, Orenstein WA,4th ed.Elsevier Inc.2004: 269-97.
  • 4. http://www.who.int/vaccines/en/hepatitisa.shtml
  • 5. Academy of Pediatrics.Hepatitis A. In: Pickering LK, Baker CJ, Long SS, McMillan JA,eds.Red Book:2006 Report of the Committee on Infectious Diseases.27th ed.Elk Grove Village, IL;American Academy of Pediatrics;2006: 326-35.
  • 6. Galazka MA. Genel İmmünoloji. Bağışıklamanın İmmünolojik Temelleri içinde Çev:Egemen A., Akşit S.TC. Sağlık Bakanlığı TSH Genel Md. Yayınları. Ankara 1993:1- 20.
  • 7. Gan R, Amir J, Livni G et al. Concomittant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial.Pediatr Infect Dis J. 2007; 26: 787-93.
  • 8. Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Eng J Med 1996; 405: 1022-8.
  • 9. Clarck HF, Offit P, Glass RI, Ward RL. Rotavirus vaccines. In: Vaccines. Plotkin SA, Orenstein WA, (eds). 4th ed. Philadelphia, Saunders,2004:1327-1345
  • 10. MP Manish, H Penina, Baggs J, et al. Intussusception and rotavirus vaccination: a review of the available evidence Expert Review of Vaccines, November 2009, Vol. 8, No. 11, Pages 1555-1564.
  • 11. Palacios GR, Schael IP, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354: 11-22.
  • 12. De Vos B, Vesikari T, Linhares AC,et al. A Rotavirus vaccine for Prophylaxis of Infants Against Rotavirus gastroenteritis Pediatr Infect Dis J 2004;23(10 suppl): S179-182.

Special Virus Vaccines - 1

Yıl 2012, Cilt: 12 Sayı: 1, 42 - 45, 01.01.2012

Öz

The aim of immunization is to prevent the vaccine-prevantable disease especially in infants and children. There are
vaccines for diseases that are not in current immunization
schedules, but are frequently detected in public.

Kaynakça

  • 1. The Pink Book: Course Textbook - 12th Edition, chapter 8.
  • 2. Prevention of Hepatitis A through active or passive immunization: Recommendations of Advisory Committee on Immunization Practices (ACIP).MMWR 2006; 55 (No. RR-7): 1-23.
  • 3. Bell BP. Feinstone SM. Hepatitis A vaccine.In: Vaccines,Ed. By Plotkin SA, Orenstein WA,4th ed.Elsevier Inc.2004: 269-97.
  • 4. http://www.who.int/vaccines/en/hepatitisa.shtml
  • 5. Academy of Pediatrics.Hepatitis A. In: Pickering LK, Baker CJ, Long SS, McMillan JA,eds.Red Book:2006 Report of the Committee on Infectious Diseases.27th ed.Elk Grove Village, IL;American Academy of Pediatrics;2006: 326-35.
  • 6. Galazka MA. Genel İmmünoloji. Bağışıklamanın İmmünolojik Temelleri içinde Çev:Egemen A., Akşit S.TC. Sağlık Bakanlığı TSH Genel Md. Yayınları. Ankara 1993:1- 20.
  • 7. Gan R, Amir J, Livni G et al. Concomittant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial.Pediatr Infect Dis J. 2007; 26: 787-93.
  • 8. Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Eng J Med 1996; 405: 1022-8.
  • 9. Clarck HF, Offit P, Glass RI, Ward RL. Rotavirus vaccines. In: Vaccines. Plotkin SA, Orenstein WA, (eds). 4th ed. Philadelphia, Saunders,2004:1327-1345
  • 10. MP Manish, H Penina, Baggs J, et al. Intussusception and rotavirus vaccination: a review of the available evidence Expert Review of Vaccines, November 2009, Vol. 8, No. 11, Pages 1555-1564.
  • 11. Palacios GR, Schael IP, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354: 11-22.
  • 12. De Vos B, Vesikari T, Linhares AC,et al. A Rotavirus vaccine for Prophylaxis of Infants Against Rotavirus gastroenteritis Pediatr Infect Dis J 2004;23(10 suppl): S179-182.
Toplam 12 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Derlemeler
Yazarlar

Selda Sivaslıoğlu Bu kişi benim

Yayımlanma Tarihi 1 Ocak 2012
Yayımlandığı Sayı Yıl 2012 Cilt: 12 Sayı: 1

Kaynak Göster

APA Sivaslıoğlu, S. (2012). Özel Virüs Aşıları - 1. Ankara Medical Journal, 12(1), 42-45.
AMA Sivaslıoğlu S. Özel Virüs Aşıları - 1. Ankara Med J. Ocak 2012;12(1):42-45.
Chicago Sivaslıoğlu, Selda. “Özel Virüs Aşıları - 1”. Ankara Medical Journal 12, sy. 1 (Ocak 2012): 42-45.
EndNote Sivaslıoğlu S (01 Ocak 2012) Özel Virüs Aşıları - 1. Ankara Medical Journal 12 1 42–45.
IEEE S. Sivaslıoğlu, “Özel Virüs Aşıları - 1”, Ankara Med J, c. 12, sy. 1, ss. 42–45, 2012.
ISNAD Sivaslıoğlu, Selda. “Özel Virüs Aşıları - 1”. Ankara Medical Journal 12/1 (Ocak 2012), 42-45.
JAMA Sivaslıoğlu S. Özel Virüs Aşıları - 1. Ankara Med J. 2012;12:42–45.
MLA Sivaslıoğlu, Selda. “Özel Virüs Aşıları - 1”. Ankara Medical Journal, c. 12, sy. 1, 2012, ss. 42-45.
Vancouver Sivaslıoğlu S. Özel Virüs Aşıları - 1. Ankara Med J. 2012;12(1):42-5.